TUBERKULYOZ MENINGITNING TASHXISOTI VA DAVOLASH SAMARADORLIGI
Article Sidebar
Main Article Content
Аннотация:
tuberkulyoz kasalligi (tuberkulyoz) dunyodagi eng keng tarqalgan yuqumli kasallikdir. So'nggi yillarda Mycobacterium tuberculosis (M. tuberculosis) ning ko'p dori-darmonlarga chidamli shtammlari paydo bo'lishi va immuniteti zaif odamlar sonining ko'payishi tufayli tuberkulyoz bilan kasallanish sezilarli darajada oshdi . Markaziy asab tizimi tuberkulyoziga tuberkulyoz meningiti (TM - eng keng tarqalgan ko'rinish), intrakranial tuberkulyomalar va umurtqa tuberkulyozli araxnoiditi kiradi. TM bilan og'rigan odamlarda holsizlik, bosh og'rig'i, isitma yoki shaxsiyat o'zgarishining dastlabki bosqichi bo'ladi, keyin ikki-uch hafta ichida uzoq davom etadigan bosh og'rig'i, insult, meningizm, qusish, ongda chalkashlik va o’choqli nevrologik o’zgarishlar kuzatiladi. Agar bu davrda davolanmasa, ruhiy o’zgarishlar holati stupor yoki komaga aylanadi. TMni davolashda kechikish o'limga yoki jiddiy nevrologik kasallikka olib keladi. Ushbu sharh tuberkulyoz meningiti bo'yicha tadqiqotlar so'nggi ishlanmalarni, asosan, ushbu kasallikdagi immun javoblari, patogenezi, diagnostikasi va davolashini o'z ichiga oladi.
Article Details
Как цитировать:
Библиографические ссылки:
WHO. Global Tuberculosis Control Report; WHO/HTM/TB/2009.411; World Health Organization: Geneva, Switzerland, 2009.
Rieder, H.L.; Snider, D.E.; Cauthen, G.M. Extrapulmonary Tuberculosis in the United States. Am. Rev. Respir. Dis. 1990, 141, 347–351. ,
Shafer, R.W.; Kim, D.S.; Weiss, J.P.; Quale, J.M. Extrapulmonary Tuberculosis in Patients with Human Immunodeficiency Virus Infection. Medicine 1991, 70, 384–397.
Tsenova, L.; Mangaliso, B.; Muller, G.; Chen, Y.; Freedman, V.H.; Stirling, D.; Kaplan, G. Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis. Antimicrob. Agents Chemother. 2002, 46, 1887–1895.
Marais, S.; Pepper, M.J.; Schutz, C.; Wilkinson, R.J.; Meintjes, G. Presentation and Outcome of Tuberculous Meningitis in a High HIV Prevalence Setting. PLoS ONE 2011, 6, e20077.
Sudha, K.; Rao, A.V.; Rao, S.N.; Rao, A. Oxidative stress and antioxidants in tubercular meningitis. Indian J. Clin. Biochem. 2002, 17, 34–41. ,
Ray, G.; Aneja, S.; Jain, M.; Batra, S. Evaluation of free radical status in orqa miya suyuqligi in childhood meningitis. Ann. Trop. Paediatr. 2000, 20, 115–120. ,
Mule, F.; Garufi, L. Variations of the glutathione level in the cerebrospinal fluid in tuberculous meningitis treated with streptomycin. La Pediatr. 1950, 58, 325–341.
Ali, T.; Bronze, M.S.; Kaitha, S.; Mahmood, S.; Ftaisi; Stone, J.; Ftesi, A. Clinical use of anti-TNF therapy and increased risk of infections. Drug Heal. Patient Saf. 2013, 5, 79–99. ,
Cavalcanti, Y.V.N.; Brelaz, M.C.A.; Neves, J.K.D.A.L.; Ferraz, J.C.; Pereira, V.R.A. Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis. Pulm. Med. 2012, 2012, 1–10.,
Chun, R.; Adams, J.S.; Hewison, M. Immunomodulation by v itamin D: Implications for TB. Expert Rev. Clin. Pharmacol. 2011, 4, 583–591. ,
Drennan, M.B.; Nicolle, D.; Quesniaux, V.J.F.; Jacobs, M.; Allie, N.; Mpagi, J.; Frémond, C.; Wagner, H.; Kirschning, C.; Ryffel, B. Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium tuberculosis Infection. Am. J. Pathol. 2004, 164, 49–57. ,
Jung, J.-Y.; Madan-Lala, R.; Georgieva, M.; Rengarajan, J.; Sohaskey, C.D.; Bange, F.-C.; Robinson, C.M. The Intracellular Environment of Human Macrophages That Produce Nitric Oxide Promotes Growth of Mycobacteria. Infect. Immun. 2013, 81, 3198–3209. ,
Hossain, M.; Norazmi, M.N. Pattern Recognition Receptors and Cytokines inMycobacterium tuberculosisInfection—The Double-Edged Sword? BioMed. Res. Int. 2013, 2013, 1–18. ,
Kiazyk, S.; Ball, T. Latent tuberculosis infection: An overview. Can. Commun. Dis. Rep. 2017, 43, 62–66.
O’Garra, A.; Redford, P.S.; McNab, F.W.; Bloom, C.I.; Wilkinson, R.J.; Berry, M.P. The Immune Response in Tuberculosis. Annu. Rev. Immunol. 2013, 31, 475–527. , .
Wilkinson, R.J.; Rohlwink, U.; Misra, U.K.; van Crevel, R.; Mai, N.; Dooley, K.E.; Caws, M.; Figaji, A.; Savic, R.; Solomons, R.; et al. Tuberculous meningitis. Nat. Rev. Neurol. 2017, 13, 581–598. ,
Thwaites, G.; Chau, T.T.; Mai, N.T.; Drobniewski, F.; McAdam, K.; Farrar, J. Tuberculous meningitis. J. Neurol. Neurosurg. Psychiatry 2000, 68, 289–299. ,
Mezochow, A.; Thakur, K.; Vinnard, C. Tuberculous Meningitis in Children and Adults: New Insights for an Ancient Foe. Curr. Neurol. Neurosci. Rep. 2017, 17, 85. ,